Overlapping Community Detection on a Graph of Chemicals, Diseases and Genes for Drug Repositioning and Adverse Reactions Prediction by García-Ochagavía, María Elena et al.
GECONTEC: Revista Internacional de Gestión del Conocimiento y la Tecnología. ISSN 2255-5648 
García-Ochagavía, M.E., Almeida-Cruz, Y., Estévez-Velarde, S., Alonso-Reina, A. y Ochagavía-
Roque, M.E. Vol. 7(2). 2019 
 
80 
 
        
Overlapping Community Detection on a Graph of Chemicals, Diseases 
and Genes for Drug Repositioning and Adverse Reactions Prediction 
 
María Elena García-Ochagavía 
mariae@matcom.uh.cu  
Universidad de La Habana  
 
Yudivián Almeida-Cruz 
yudy@matcom.uh.cu  
Universidad de La Habana 
  
Suilán Estévez-Velarde 
sestevez@matcom.uh.cu  
Universidad de La Habana 
 
Aimée Alonso-Reina 
a.alonso@matcom.uh.cu 
Universidad de La Habana 
  
María Elena Ochagavía-Roque 
ochagavia@nauta.cu  
Centro de Ingeniería Genética y Biotecnología 
ABSTRACT 
Developing a drug from scratch is a very long and expensive process that has a small 
probability of success. For this reason, pharmaceutical companies are devoting their efforts to 
find drugs that could be repositioned. When using a drug to treat a disease is necessary to 
consider what adverse reactions it may cause, this is why the prediction of adverse reactions is 
highly related to drug repositioning. We propose the detection of overlapping communities over 
a biological network of chemicals, diseases and genes in order to find drug-disease pairs that 
could be used as basis for later drug repositioning and adverse reactions prediction analysis. Of 
the evaluated overlapping community detection algorithms, OSLOM got the best results, 
producing 724 communities from which was possible to extract 215944 drug-disease pairs not 
present in the analyzed graph. We illustrate the usefulness of this set through examples of 
associations between pairs found in the scientific literature. 
KEYWORDS: Drug repositioning, adverse reactions, overlapping community detection, 
biological network 
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INTRODUCTION 
Developing a drug from scratch is an expensive process that takes several years and has a very 
small probability of success. For this reason, several pharmaceutical companies are using the 
strategy of reusing licensed drugs for new medical indications, this practice is call drug 
repositioning. 
Drug repositioning has several advantages over the traditional process of developing a drug. The 
primary advantage is that the drug to be reused have already passed a high number of toxicity 
tests and many of its side effects are known. Hence, a repositioned drug has a higher probability 
of success and the cost of developing it and introducing it in the market with a new functionality 
is lower. When administering a new drug to a patient, the doctor must consider the possible side 
effects it might have, for this reason the prediction of adverse reactions to drugs is a subject that 
is deeply related to drug repositioning.   
Multiple strategies have been used to reposition drugs, such as the search of drugs with chemical 
similarity, the modeling of physical interaction and virtual screening of compound libraries 
(Eckert and Bajorath 2007). With these strategies the problem is reduced to find chemicals 
capable of reestablish the affected pathway. However, the complex biological network in which 
they interact is not taken into account.  
The accumulation of biological data in recent years have made possible to start using biological 
networks as basis for the development of drug repositioning methods. The search of common 
molecular mechanisms between drugs and diseases and the use of supervised inference methods 
(Chen, Zhang et al. 2015) are some of the explored strategies.  
Another strategy to drug repositioning using biological networks has been the detection of 
communities. In a previous work (Wu, Gudivada et al. 2013), a network was built from gene-
disease and gene-drug relationships extracted from KEGG(Kanehisa and Goto 2000). In the 
built network, drugs and diseases are represented by nodes while an edge exists between two 
nodes if they share relationships with genes, biological processes, pathways or combinations of 
these characteristics. This network was used to detect non-overlapping communities of drugs 
and genes. Finally, from each community all drug-disease pairs were generated and proposed as 
candidates for a latter drug repositioning analysis.  
When detecting communities on biological networks, its complex nature makes it likely that a 
node may belong to more than one community. Taking this into consideration, we propose a 
similar approach using overlapping communities instead of non-overlapping communities. 
In the present work an analysis of overlapping community detection was performed over a graph 
of chemicals, diseases and genes generated from a database that integrates extensive biological 
information from multiple online publicly available sources: BisoPharma (Ochagavia, Martin et 
al. 2003). 
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OVERLAPING COMMUNITY DETECTION ALGORITHMS 
A number of overlapping community detection algorithms have been developed using different 
strategies such as: clique percolation, line graph and link partitioning, local expansion and 
optimization, fuzzy detection and agent-based and dynamic algorithms. In the current section 
some of them will be reviewed. 
The Clique Percolation Method (CPM)(Palla, Derenyi et al. 2005) assumes that a community is 
a set of overlapped fully connected subgraphs. CPM identifies all cliques of size k and creates a 
new graph where nodes represent the k-cliques in the original graph and an edge exists between 
two nodes if the k-cliques that they represent have k-1 nodes in common. The connected 
components of the new graph determine the overlapping communities by considering a 
community as the union of the k-cliques represented by the nodes in a connected component. 
Various adaptations of CPM have been developed, such as CPMw, an adaptation of CPM for 
weighted graphs (Illés, Dániel et al. 2007).  
Line Graph and Link Partitioning algorithms are based in the idea of partitioning edges instead 
of nodes. This way, if a node has two edges assigned to different clusters, this node belongs to 
both communities causing the communities to overlap. This approach has the advantage that 
allows hierarchical clustering in a simple manner by using a hierarchical disjoint community 
detection algorithm over the links (Ahn, Bagrow et al. 2010). 
Local Expansion and Optimization algorithms are based on creating a natural community or a 
partial community by optimizing a local function that measures the quality of communities. 
Baumes (Baumes, Goldberg et al. 2005) proposes a combination of two algorithms to follow 
this approach: Ranck Removal(RaRe) and Iterative Scan(IS). RaRe finds small connected 
components that serve as seed communities to expand by IS by adding or removing nodes to 
optimize a local density function. LMF (Lancichinetti and Fortunato 2009) expands communities 
from randomly selected nodes. MONC (Frank, Michael et al. 2011) uses a modification of LFM’s 
fitness function that allows a node to be a community by itself. OSLOM (Lancichinetti, Radicchi 
et al. 2011) uses the statistical significance as a metric to evaluate communities and calculates the 
statistical significance of a community as the probability to find it in the null model: the 
configuration model (Molloy and Reed 1995). EAGLE (Andrea, Santo et al. 2009) is an 
agglomerative algorithm that starts by the set of maximal cliques of size higher that a parameter 
k. It creates a dendrogram by merging the two more similar communities in each step. Finally, 
it cuts the dendrogram in the level that yields the highest value of a modified modularity measure 
to obtain the cover.   
Fuzzy community detection algorithms model the association of a node to a community as a real 
number between zero and one that represents the strength of the association. They calculate a 
soft membership vector for each node. A disadvantage of these algorithms is the need to know 
a priori the length of the vector (the number of communities). Nepusz (Nepusz, Petroczi et al. 
2008) models the fuzzy community detection problem as a nonlinear constrained optimization 
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problem that can be solved using simulated annealing methods. Zhanga (Zhanga, Wangb et al. 
2006) proposes an approximate mapping of the graph into a Euclidian space and then uses a 
fuzzy c-means clustering to find the communities. Another approach to fuzzy community 
detection is the use of mixture models due to their probabilistic nature, this is the case of SPAEM 
(Derenyi, Palla et al. 2005). 
Label Propagation Algorithm (LPA) (Raghavan, Albert et al. 2007) is a non-overlapping 
community detection algorithm where communities are detected by label propagation with an 
almost linear running time. It begins by assigning a label to each node and during each iteration 
each node is assigned the most frequent label among its neighbors. COPRA (Gregory 2010) is 
an LPA generalization for overlapping community detection that receives as a parameter the 
maximum numbers of communities that a node can belong to. Another adaptation of LPA is 
SLPA (Xie, Szymanski et al. 2011) which is based on a speaker-listener information propagation 
process.  
 
QUALITY METRICS FOR OVERLAPPING COMMUNITIES 
The selection of the best algorithm to find a cover for a specific network requires the use of 
metrics to evaluate the quality of the cover. Also, metrics that evaluate the quality of communities 
are necessary to find the most interesting communities for drug repositioning purposes. 
Community quality metrics 
The use of metrics to evaluate the quality of a cover is necessary in order to select the best 
algorithm. There is no exact definition of what constitutes a community, however there is a 
widely accepted notion that a community is a subset of nodes of the graph that are more densely 
connected among them that with the rest of the graph. The metrics shown in Table 1 are based 
on the previous notion.  
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Table 1 Community quality metrics 
Metric Formula Description 
Conductance 
(Leskovec, Lang et 
al. 2010) 
݂ሺܵሻ ൌ ܿௌ2݉ௌ ൅ ܿௌ ሺ1ሻ
 
Measures the fraction of 
total edge that points outside 
the cluster 
Expansion 
(Leskovec, Lang et 
al. 2010) 
݂ሺܵሻ ൌ ܿௌ݊ௌ ሺ2ሻ
 
Measures the number of edges 
per node that point outside 
the cluster 
Internal density 
(Leskovec, Lang et 
al. 2010) 
݂ሺܵሻ ൌ 1 െ ݉ௌ݊ௌሺ݊ௌ െ 1ሻ/2 ሺ3ሻ
 
Measures the internal edge 
density of the cluster 
Cut Ratio 
(Leskovec, Lang et 
al. 2010) 
݂ሺܵሻ ൌ ܿௌ݊ௌሺ݊ െ ݊ௌሻ ሺ4ሻ
 
Measures the fraction of all 
possible edges leaving the 
cluster 
Baumes Density 
(Baumes, 
Goldberg et al. 
2005) 
ௗ݂௕ሺܵሻ ൌ ݉ௌ݉ௌ ൅ ܿௌ ሺ5ሻ
 
Measures the fraction of the 
total of edges with both nodes 
inside the community with 
respect to the total number of 
edges with at least one node in 
the community 
Difference 
between intra-
cluster and extra-
cluster density 
(Fortunato 2010) 
ௗ݂௜௙ሺܵሻ ൌ ݉ௌ݊ௌሺ݊ௌ െ 1ሻ/2 െ
ܿௌ
݊ௌሺ݊ െ ݊ௌሻ ሺ6ሻ
 
Is tradeoff be-tween internal 
density and cut Ratio 
Legend: ܵ is the community being evaluated, ݊ௌ is the number of nodes in ܵ, ݉ௌ is the number of edges between nodes of ܵ and ܿௌ is the number 
of edges with exactly one node in ܵ 
 
When using the metrics ሺ3,ሺ5ሺ6 the higher the value the better the community and in the resting 
metrics occurs the opposite. The metrics of equations ሺ1, ሺ5 and ሺ6 were considered of interest 
in this work because all of them take into account both: that the nodes of the graph are well 
connected internally and poorly connected to the rest of the graph. However, the metrics ሺ1 and 
5	are highly correlated, thus it would be redundant to use both.  
Cover quality metrics 
In the scientific literature there are several generally accepted metrics that allow to evaluate the 
quality of partitions, but that is not the case for evaluating the quality of covers. For this reason, 
several authors have used adaptations of metrics that where originally created to evaluate the 
quality of partitions. 
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The most popular quality function to evaluate partitions is Newman and Girvan Modularity 
(Girvan and Newman 2002). Several previous works have developed cover detection algorithms 
based in modularity optimization using adaptations of Newman and Girvan Modularity to allow 
community overlapping. However, none of these adaptations have become a generally used 
metric to evaluate the quality of covers. 
The use of additive functions is another commonly used approach to evaluate partitions 
(Fortunato 2010). In this approach the quality of a partition is determined by the summation of 
the qualities of each community of the partition. When evaluating a partition, the number of 
summands, which is equal to the number of communities, is limited by the number of nodes in 
the graph, but this is not the case for covers, where the number of summands (communities) is 
only limited by the amount of possible subsets of nodes of the graph. This makes the use of 
additive functions not appropriate to evaluate covers without normalizing. 
 
OVERLAPPING COMMUNITY FOR DRUG REPOSITIONING AND ADVERSE 
REACTIONS PREDICTIONS 
This research proposes an overlapping community detection analysis on a graph of chemicals, 
disease and genes in order to find drug-disease pairs to be considered as candidates for drug 
repositioning or that could cause adverse reactions.  
Graph of chemicals, diseases and genes (CDG) 
The analysis of overlapping community detection in biological network proposed in this research 
was performed on a graph which nodes represent biological entities like chemicals, diseases and 
genes and its edges represent gene-chemical, gene-disease and chemical-disease associations. The 
information used to generate this graph was extracted form BisoPharma (Ochagavia, Martin et 
al. 2003) database.    
BisoPharma is a system for biological network generation and visualization, composed by tree 
main components: a relational database, a web service and a Cytoscape’s plugin (Shannon, 
Markiel et al. 2003) that plays the role of a client application. The BisoPharma database integrates 
data related to chemical, diseases and genes extracted from multiple online publicly available 
sources. This sources are: CTD (Davis, Grondin et al. 2015), OMIM (Amberger, Bocchini et al. 
2015), GAD (Becker, Barnes et al. 2004), NHGRI GWAS Catalog (Welter, MacArthur et al. 
2014), TTD (Yang, Qin et al. 2016), DRUGBANK (Wishart, Knox et al. 2006), SysBiomics 
(Martin, Ochagavia et al. 2010), DO (Kibbe, Arze et al. 2015) and MeSH1. 
                                                 
 
 
1 https://www.nlm.nih.gov/mesh 
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The graph obtained from BisoPharma has 79400 nodes and 722715 edges. It contains 31066 
connected components, of which all except one have 6 nodes or less. The largest connected 
component has 47255 nodes and 721634 edges. The study of the small connected components 
of the graph has no value for an analysis of community detection, for this reason in this research 
only the largest component was considered. The proportions of each node type and edge type 
in the final graph are shown in the figures Figure 1 and Figure 2, respectively. 
 
 
Figure 1 Bioentities proportion 
 
Figure 2 Biorelations proportion 
 
The Cytoscape’s plugin NetworkAnalyzer (Assenov, Ramírez et al. 2008) version 3.2.1 was used 
for a more thorough analysis of the graph. Figures Figure 3, Figure 4 and Figure 5 show the 
degree distribution, the minimum cost path distribution and the number of common neighbors’ 
distribution respectively. 
Cover detection in CDG 
The selection of criteria to compare the selected algorithms was necessary to obtain the best 
cover. These criteria include the selection of metrics to evaluate the quality of communities and 
covers and the development of a strategy to compare the overall performance of the algorithms. 
The used methodologies are described in the following sections. 
 
Figure 3 Node degree distribution 
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Figure 4 Minimum cost path distribution 
 
Figure 5 Common neighbors’ distribution 
Selection of community quality metric 
The metrics Baumes density and difference between intra-cluster and extra-cluster density were 
used to evaluate the quality of the communities obtained from CDG. These metrics were 
selected because they consider a balance between a high amount of internal edges and a small 
amount of intra cluster edges, which fits the idea that a community is a set of nodes more 
connected internally than to the rest of the graph. However, for both metrics the resulting value 
is affected by the size of the community as shown in figure Figure 6 and Figure 7.  For this 
reason, equal resulting values of the metrics, yielded from communities of different size, do not 
have the same meaning, thus it is not convenient to use them to compare communities of 
different sizes.  
 
Figure 6 Relation between Baumes density and the size of a 
community 
Figure 7 Relation between the Difference between intra-cluster and 
extra-cluster density and the size of a community 
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As a solution to this problem, a z-score for each community size was created for both metrics. 
A z-score measures how far is a sample value from the population’s mean in units of the standard 
deviation. To build a z-score form the selected metrics, the mean and the standard deviation for 
subgraphs of size k were estimated generating random sets of nodes of size k for each possible 
community size k. The resulting metrics were: 
 
ௗ݂௕ᇱ ሺܵሻ ൌ ௗ݂௕ሺܵሻ െ ܺௗ௕
ௌ
ߪௗ௕ௌ  
ሺ7ሻ
 
ௗ݂௜௙ᇱ ሺܵሻ ൌ ௗ݂௜௙
ሺܵሻ െ ܺௗ௜௙ௌ
ߪௗ௜௙ௌ  
ሺ8ሻ
Where ܺௗ௕ௌ ሺܺௗ௜௙ௌ ሻ and ߪௗ௕ௌ ሺߪௗ௜௙ௌ ሻ represent the estimated mean and standard deviation of  
ௗ݂௕ሺ ௗ݂௜௙ሻ evaluated on graph of the same size as S. 
Definition of cover quality criteria 
Additive normalized metrics based on equations ሺ7 and ሺ8 where used to evaluate the quality of 
covers. The resulting formulas are: 
 ܳௗ௕ሺܥሻ ൌ ∑ ௗ݂௕
ᇱ ሺܵሻௌ∈஼
ܿ  ሺ9ሻ
 ܳௗ௜௙ሺܥሻ ൌ
∑ ௗ݂௜௙ᇱ ሺܵሻௌ∈஼
ܿ  ሺ10ሻ
For this work, it was decided to discard communities larger than 1000 because it is 
computationally expensive to estimate the mean and the standard deviation for large community 
sizes. Also, the objective of this work is to use the resulting communities for a later analysis of 
drug repositioning, for which loo large communities are not convenient. 
When discarding communities of size higher than 1000 is likely that some nodes are not assigned 
to a community. This makes necessary to take into account the amount of nodes not assigned 
to any community when comparing covers. 
Another criterion that is necessary to consider is the amount of communities of a single node 
(singleton). 
Summing up, the criteria used to evaluate covers are: 
1- The average of the z-score of Baumes density of each community 
2- The average of the z-score of the difference between intra-cluster and extra-cluster 
density of each community 
3- Amount of nodes not assigned to any community (assigned only to communities with 
more than 1000 nodes). 
4- Amount of singletons 
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Experiments design  
The algorithms OSLOM, COPRA and SLPA were selected to be used on the graph CDG 
because of their good performance over sparse networks (Xie, Kelley et al. 2013). Several 
parameter values were evaluated for each method in order to obtain their optimal behavior in 
the community detection goal.  
In OSLOM the p-value was set to 0.05, 0.10 and 0.15. This parameter establishes the significance 
threshold for communities. The cover parameter, which is used by the algorithm to decide to 
keep some modules or their union, was evaluated for values 0.25, 0.5 and 0.75. 
In COPRA only the parameter v was explored, this paremeter determines the maximum number 
of communities to which a node can belong. I was set to values ranging from 1 to 10 with a step 
of 1. 
In SLPA parameters r and v were investigated. In SPLA each node receives a value between 0 
and 1 which represents its degree of belonging to each community. The parameter r establishes 
a belonging threshold that determines the binary assignment of a node to a community. The v 
parameter establishes the selected interaction rule and can take values 1, 2 or 3 each of which 
represents a specific rule. In this work SLPA was ran using all possible interaction rules and r 
values of 0.01, 0.05, 0.1, 0.15, 0.2, 0.25, 0.3, 0.35, 0.4, 0.45 and 0.5. 
To obtain the best parameter combination for each method the criteria discussed in the previows 
section were combined as follows. First, each combination was evaluated using each criterion 
separately to create a ranking per criterion and, afterward, a general ranking was created summing 
the ranks of each combination regarding each criterion. Finally, to select the best method, the 
covers yielded by running each algorithms with the best parameter combination, were compared 
using the same methodology. 
 
RESULTS AND DISCUSSIONS 
The results of evaluating the selected parameter combinations using the previously discused 
criteria yielded that the best combinations were v = 3 and r = 0.45 for SLPA, p-value = 0.10 and 
cover = 0.25 for OSLOM and v = 14 for COPRA. 
Each algorithm was excecuted 30 times using the best parameter combinations to obtain 
statisticaly significant results, which are shown in Table 2. The best results were obtained from 
the algorithm OSLOM, because it did not produced singletons, only a small number of nodes 
were not assigned to communities and it yielded the best result of the difference between intra-
cluster and extra-cluster density. The best results of Baumes density were obtained by COPRA, 
however, it produced a high number of singletons and obtained the worst results of the 
difference between intra-cluster and extra-cluster density. 
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Table 2 Algorithms Results 
Algorithm NAN NANR S SR B BR DIE DIER Sum 
OSLOM 595.43 1 0 1 22837.92 3 9983.84 1 6 
SLPA 15982.67 3 0 1 34786.39 2 6740.79 2 8 
COPRA 7598.57 2 39250 3 182057.34 1 5753.40 3 9 
Legend: NAN is the number of nodes not assigned to any community, NANR is the NAN ranking, S is the number of singletons, SR is the S 
ranking, B is the Baumes  Density, BR is the B Ranking, DIE is the Difference between intra-cluster and extra-cluster density and DIER is 
DIE Ranquing. 
 
The cover proposed to perform drug reposition analysis was generated by OSLOM because it 
obtained the best results of the metrics. The cover contains 724 communities, most of which 
have an appropriated size for visual inspection (between 50 and 150 nodes as can be seen in 
Figure 8 Community size distributionFigure 8). Figure 9 shows the Baumes density distribution 
while Figure 10 shows the difference between intra-cluster and extra-cluster density distribution.  
 
Figure 8 Community size distribution 
 
Figure 9 Baumes density distribution 
In this work it is proposed the list of all drug-disease pairs assigned to the same community as 
candidates to perform drug repositioning analysis. This is based in the idea that drugs and 
diseases in the same community are likely to share molecular mechanisms. 
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Figure 10 Difference between intra-cluster and extra-cluster density distribution 
The list contains 215944 drug-disease pairs of which only 15406 (7.13%) exist in BisoPharma, 
leaving a large amount of pairs to be explored. In order to illustrate the usefulness of this cover, 
some communities were analyzed more thoroughly, and some associations of the proposed pairs 
were found in the literature. ¡Error! No se encuentra el origen de la referencia.3 shows some 
examples of these associations.  
Table 3 Drug-disease associations fount in the literature 
Drug Disease Association Type Reference 
Atenolol Schizophrenia Repositioning 2 
Atenolol Akathisia, drug 
induced 
Repositioning 4 
Teicoplanin Cellulitis Repositioning (Turpin, Taylor et al. 
1988) 
Etanercept Parakeratosis Adverse Reaction (Echeverri, Vidal et 
al. 2015) 
Levodopa Carcinoma and 
squamous cell 
Adverse Reaction 3 
Efedrina Parkinson Disease Adverse Reaction (Sikk, Haldre et al. 
2011) 
Leucovorin Dariel Disease Repositioning (Holcmann and 
Sibilia 2015) 
In the following paragraphs some of these associations will be explained with more detail. The 
community shown in ¡Error! No se encuentra el origen de la referencia. contains Atenolol 
                                                 
 
 
2 http://www.schizophrenia.com/szresearch/archives/001174.html 
3http://www.labome.org/research/Basal-cell-carcinoma-and-squamous-cellcarcinoma-in-a-patient-with-
Parkinson-disease.html 
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and Schizophrenia with no edge between them, nevertheless the search in the literature of this 
pair showed the following: when treating schizophrenic patients is common the use of 
antipsychotics which may have as a side effect akathisia. Akathisia is a state of severe restlessness 
that could lead to suicide. One of the treatments for akathisia is the oral administration of beta-
blockers like Atenolol. This is an example of the use of Atenolol with positive effect on patients 
with Schizophrenia. 
The community shown in 2 contains Leucovorin and Darier’s disease without a direct link 
between them. However, the research of the literature yielded a patent (Holcmann and Sibilia 
2015) that protects the treatment with epidermal growth factor receptor (EGFR) inhibitors, like 
Leucovorin, of genetic skin disorders that exhibit a high percentage of penetrance, or complete 
penetrance, such as Darier's disease. This is an example of successful repositioning of the drug 
Leucovorin to treat Darier’s disease. 
  
Figure 11 Association between Atenolol and Schizophrenia 
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Figure 12 Association between Leucovorin and Darier’s disease 
 
CONCLUSIONS 
Recently, several pharmaceutical companies are devoting their efforts to find drugs that could 
be repositioned. This is because the traditional process of developing a drug is very long, 
expensive and has a small probability of success. When considering a drug to be repurposed to 
treat another disease, it is necessary to take into account the adverse reactions that it may cause 
when targeting this disease. For this reason, the prediction of adverse reactions is highly related 
to the search of drugs candidates to be repositioned. 
We approached the subject of finding drugs candidates to be repositioned and adverse reaction 
prediction through an overlapping community detection analysis of a complex biological 
network built from BisoPharma database.  
The algorithms considered to detect communities over the graph were OSLOM, SLPA and 
COPRA. These algorithms were compared using additive normalized metrics based on Baumes 
density and the difference between intra-cluster and extra-cluster density. The evaluation of the 
covers resulting from these algorithms indicated that OSLOM generated the best cover.  
Finally, we provide the list of drug-disease pairs contained in the same community of the 
obtained cover to be used as base for drug repositioning analysis and adverse reaction prediction. 
The usefulness of this list was illustrated through examples of associations between pairs found 
in the scientific literature.  
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